# Topical Naloxone to Diagnose Ocular Pain

> **NCT04454281** · PHASE1 · COMPLETED · sponsor: **Seema Capoor** · enrollment: 1 (actual)

## Conditions studied

- Dry Eye Syndromes
- Neuropathic Pain

## Interventions

- **DRUG:** Naloxone Hydrochloride 0.4 MG/ML

## Key facts

- **NCT ID:** NCT04454281
- **Lead sponsor:** Seema Capoor
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2020-12-03
- **Final completion:** 2020-12-03
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454281, "Topical Naloxone to Diagnose Ocular Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04454281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*